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Abstract
RNA sequencing is a molecular technique which utilizes next generation 
sequencing to identify and quantify ribonucleic acid (RNA) in a given sample. This 
technique is utilized in the detection of changes in gene expression. Potentially 
malignant oral disorders are one of the most troublesome lesions seen in the oral 
cavity which predisposes to the development of oral cancer. Though there are many 
methods employed in the diagnosis of these disorders, biopsy followed by histologi-
cal examination is the gold standard procedure followed in the diagnosis. RNA 
sequencing has been receiving attention among researchers. Many studies have 
been conducted to analyze the application of RNA sequencing in the diagnosis of 
PMODs as well as in the malignant transformation to oral squamous cell carcinoma. 
The article attempts to summarize the progress in RNA sequencing pertaining to 
Potentially malignant disorders.
Keywords: RNA sequencing, Potentially Malignant Disorders, Diagnostic Markers, 
Molecular Diagnosis, Oral cancer
1. Introduction
RNA sequencing is a molecular technique which utilizes next generation 
sequencing to identify and quantify ribonucleic acid (RNA) in a given sample. 
This technique is utilized in the detection of changes in gene expression [1]. It also 
detects mutations or single nucleotide polymorphisms etc. RNA sequencing has 
greatly replaced cDNA microarray owing to more precise reproduction of using 
lanes and flow cells. Another added bonus is that this method allows de novo recon-
struction of the transcriptome i.e., unknown material can be analyzed [2].
Potentially malignant oral disorders are one of the most troublesome lesions 
seen in the oral cavity which predisposes to the development of oral cancer. As the 
saying goes, “prevention is better than cure” it is better to identify and tackle the 
lesion in the premalignant stage rather than once cancer has developed. Sarode et 
al. (2014) defined OSCC prone disorders as ‘It is a group of disorders of varying 
etiologies, usually tobacco; characterized by mutagen-associated, spontaneous or 
hereditary alterations or mutations in the genetic material of oral epithelial cells 
with or without clinical and histomorphological alterations that may lead to oral 
squamous cell carcinoma transformation’ [3].
Though there are many methods employed in the diagnosis of these disorders, 
biopsy followed by histological examination is the gold standard procedure followed 
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in the diagnosis [4]. Molecular techniques like PCR, ELISA are attempted in iden-
tifying a sensitive and specific marker. A handful of markers (salivary and serum) 
are attempted but none are identified to lack both specificity and sensitivity ideally 
required by a diagnostic marker. Microarray has emerged as a promising method as it 
helped in comparison and analysis of multiple samples at the same time. RNA sequenc-
ing has been receiving attention among researchers [3, 4]. Many studies have been 
conducted to analyze the application of RNA sequencing in the diagnosis of PMODs as 
well as in the malignant transformation to oral squamous cell carcinoma [5, 6].
2. RNA sequencing
RNA sequencing is the molecular technique in which the quantity as well as the 
sequence of RNA in a biological sample tissue of choice is determined using next 
generation sequencing. Here, the coding and noncoding RNAs or in short the tran-
scriptome of the gene is analyzed. It was first described a decade ago. During the 
infant period of this technique, the Sanger sequencing technology was used in RNA 
sequencing which is greatly replaced in the present by more accurate next genera-
tion sequencing technology. RNA sequencing is found to be superior to many other 
techniques especially tissue microarray hybridisation [7]. The proposed advantages 
of the former over the later are:
• Microarray hybridisation requires use of species specific probe. It cannot be 
used to identify a novel or unknown sequence. RNA sequencing on the other 
hand can be successfully employed in the identification as well as quantifica-
tion of an unknown sequence.
• Background signal or non-specific binding Is less in RNA sequencing as 
compared to microarray.
• Quantification of the transcriptome is more reliable in RNA sequencing as 
compared to microarray.
• RNA sequencing has greatly replaced cDNA microarray owing to more precise 
reproduction of using lanes and flow cells.
3. Steps in RNA sequencing
The procedure of RNA sequencing is performed by three steps:
1. RNA isolation
2. RNA selection or depletion
3. cDNA synthesis
4. Preparing sequencing library
5. Next generation sequencing
The first step in RNA sequencing is the isolation of RNA from the sample 
provided. The main requirement is that the sample should possess RNA of sufficient 
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quality to enable library sequencing. Based on the quality of the RNA, measured by 
a bioanalyser an RNA integrity number is given ranging from 1 to 10. The number 
10 shows least degradation of RNA with highest quality. RNA of low quality may 
result in erroneous sequencing.
The next step is the selection of RNA species from the pool of total RNA includ-
ing mRNA, tRNA, rRNA etc. in this pool, around 95% is contributed by rRNA 
and are removed before sequencing as it may have the tendency to overshadow 
the read of other types of RNAs. This can be achieved by many techniques, like 
selecting poly A RNAs by targeted reaction with poly-T- oligos in magnetic beads. 
There are also commercially available kits which deplete the rRNA like Ribozero 
or Ribominus. In another method, the sample is treated with the enzyme, DNAse 
to reduce the quantity of the genetic material (DNA) in it. The quantity of RNA 
is determined by either capillary or gel electrophoresis. In the final step, the iso-
lated RNA is then transcribed to DNA. DNA is more stable than RNA and thereby 
facilitates techniques of amplification without undergoing damage. Also, most of 
the sequencing libraries require DNA. This cDNA is then utilized in next generation 
sequencing (Figure 1) [8].
4. Advantages and disadvantages of RNA sequencing
Advantages of RNA sequencing are
Figure 1. 
Steps in RNA sequencing.
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1. We can do genome wide analysis as well as targeted analysis
2. It can analyze both novel sequences as well as known sequences
3. It has very low background noise
4. It is cheaper in comparison to Sanger sequencing
The drawback of RNA sequencing is that the depth of coverage depends on the 
sequenceability [9].
5. RNA sequencing in potentially malignant oral disorder
Since the scope of this current chapter is the role of RNA sequencing in the 
detection of potentially malignant oral disorders. This particular technique has 
gained attention in the identification of these disorders. The studies have focused 
mainly on leukoplakia, oral submucous fibrosis and also in lichen planus.
6. RNA sequencing in leukoplakia
Oral leukoplakia is the most commonly reported potentially malignant oral 
disorder. World Health Organization (WHO)defined oral Leukoplakia as “a white 
patch or plaque that cannot be characterized clinically or pathologically as any other 
disease” [9].
Leukoplakia is at present defined as “A white plaque of questionable risk hav-
ing excluded (other) known diseases or disorders that carries no increased risk for 
cancer” (WHO 2005).
Diagnosis of Leukoplakia is predominantly based on clinical appearance as 
histological appearance seems varied. Microscopical architecture presents with a 
non-specific pattern of atrophy or hyperplasia. Histological evaluation is mainly 
done to delineate the presence and absence of epithelial dysplasia as malignant 
transformation rate is about 2–3% [9].
Numerous metabolic and molecular pathways are altered in leukoplakia and the 
disease is manifested as a culmination of all the altered metabolic pathways.
Numerous studies are conducted in analyzing the role of RNA sequencing 
leukoplakia. Philipone et al. in 2016 conducted a study which utilized deep 
RNA sequencing in the role of miRNA in both dysplastic and non-dysplastic 
leukoplakia. The predictive value of these markers were analyzed in both the 
groups. miRNA shows possible predictive value in the progression of dysplastic 
leukoplakia [10].
Another study by Chang et al. in 2019 conducted a study to analyze the role of 
potential miRNAs in the malignant transformation of leukoplakia to oral squamous 
cell carcinoma. They used small RNA sequencing to screening these markers in 
patients with leukoplakia and normal subjects. Further bioinformatics study 
revealed that miRNA-423-5p and miRNA-222-3p were found to have significance 
in the diagnosis of oral leukoplakia. RNA sequencing helped in revealing the role of 
these markers as potential diagnostic markers in leukoplakia as well as in the detec-
tion of malignant transformation [11].
Simming Zu et al. in 2020, analyzed the role of circular RNAs in the develop-
ment of leukoplakia and identified circHLA-C has role in the progression of the 
disease using Sanger sequencing. They reported that levels of circHLA-C increases 
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with degree of dysplasia. It is a potential diagnostic marker and a genetic marker in 
oral leukoplakia [12].
Transcriptome analysis was conducted using RNA sequencing, differential 
expression in the study reported by Farah et al. (2019) which evaluated leukoplakia 
cases with or without dysplasia. They concluded from their study that reactive 
changes in the connective tissue of the lesion is an early manifestation of develop-
ment of dysplasia in leukoplakia. Utilization of RNA sequencing in detection of 
molecular changes in oral leukoplakia will help in understanding the evasive process 
of development of the disease [9].
The studies conducted evaluated the role of various markers in diagnosis, pre-
diction of the disease. The studies also revealed that the molecular pathways of the 
disease can be determined by RNA sequencing. It is also suggested that as the degree 
of dysplasia increases the progression of disease also advances. RNA sequencing 
may be helpful in filling the blanks in understanding the molecular and biological 
pathways in the development of leukoplakia (Figure 2).
7. RNA sequencing in oral submucous fibrosis
Oral submucous fibrosis may be defined as “an insidious, chronic disease affect-
ing any part of the oral cavity and sometimes the pharynx. Although occasionally 
preceded by and/or associated with vesicle formation, it, is always associated with 
a juxta-epithelial inflammatory reaction followed by a fibroelastic change of the 
lamina propria, with epithelial atrophy leading to stiffness of the oral mucosa and 
causing trismus and inability to eat” [13]. ‘Slowly progressive disease characterised 
by the fibrous bands in the oral mucosa, ultimately leading to severe restriction of 
mouth movement including the tongue’ World Health Organization (1978).Oral 
submucous fibrosis is highly prevalent in South east Asia owing to the increased 
consumption of arecanut. Arecoline was identified as the single most important 
etiological agent in the development and the progression of the disease. It has a high 
malignant transformation rate of 7–30% [13].
Several studies analyzed the molecular profile of Oral sub mucous fibrosis and 
revealed that the rna profile was altered significantly in OSMF. Tsai et al. reported 
that role of the prime etiological agent areca nut lead to consistent elevation of 
miRNAs. Research evidences have substantiated the role of miRNAs in development 
of oral potentially malignant disorders [14].
Shangui Zhou et al. in 2019 conducted a study to determine the role of 
Intergenic/intertwining long RNA (IncRNAs) expression in OSMF. They used RNA 
Figure 2. 
Applications of RNA sequencing in leukoplakia.
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sequencing to transcript the samples and found that 231 IncRNAs were upregulated 
and 456 were downregulated. IncRNAs were found to be associated with the regula-
tion of progression of OSMF. These markers also plays a role in the inflammatory 
signaling associated with this disorder. This study was considered the first study 
to evaluate the role of IncRNA expression in the progression of oral submucous 
fibrosis [15].
Xiaohuan Zhong et al. studied the role of oral microflora in the development of 
oral submucous fibrosis and in the malignant transformation with continued use 
of arecanut. The genra of bacteria varied with site as well as conditions like alcohol 
or smoking. In patients with alcoholism and arecanut chewing, Prevotella was 
increased but at the same time Actinobacillus was reduced. But they suggested that 
since the sample size was small it was difficult to analyze the role of confounding 
factors in the oral bacterial dysbiosis [16].
The studies conducted in oral submucous fibrosis using RNA sequencing suggest 
the possible role in analyzing the rate of progression of the condition and also in the 
malignant transformation to oral squamous cell carcinoma. Also, one of the reasons 
for the poor prognosis of OSMF was because of lack of proper understanding of 
the molecular pathogenesis and the pathway of progression to oral squamous cell 
carcinoma (Figure 3).
8. RNA sequencing in oral lichen planus
Lichen planus is an inflammatory mucocutaneous disease involving skin, hair, 
nails and mucosal surfaces- esophageal, genital, oral, ocular, optic and less com-
monly bladder, nasal, laryngeal and anal mucosa. It is derived from the Greek word 
“leichen” means tree moss and Latin word “planus” means flat [17].
It is a T cell mediated autoimmune disorder in which cytotoxic CD8 + T cells 
trigger apoptosis of the basal cells of the oral epithelium. Associated with other 
autoimmune disorders like myasthenia gravis, alopecia, vitiligo, ulcerative colitis. 
The disease has been implicated to be caused by exogenous trigger also. One of 
the common difficulties in studying tis disorder because of the overlap between 
features of oral lichen planus and other oral mucosal conditions, to the highly vari-
able application of diagnostic criteria and the potential co-existence of additional 
non-OLP inflammatory conditions in same patients [17].
It can be defined as “Lichen planus is a chronic immunological mucocutaneous 
disorder that varies in appearance from keratotic to ulcerative (Wilson)” [17].
“Oral lichen planus is a non-infectious, cytotoxic T-cell mediated, chronic 
inflammatory autoimmune disease affecting oral cavity, involves the oral mucosal 
stratified squamous epithelium and underlying lamina propria which may be 
accompanied by skin lesions” [17].
In a study conducted by Ku Wang et al. in 2016, the role of oral microbial flora in 
oral lichen planus. MiSeq sequencing was done to detect the species present in the 
saliva of the patients and then compared the results with that of normal patients. 
There was an upsurge in Porphyromonas and Solobacterium and reduced numbers 
Figure 3. 
Applications of RNA sequencing in oral submucous fibrosis.
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of Hemophilus, Corrynebacterium, Cellulosimicrobium and Camplyobacter. 
In patients erosive lichen planus it was found that was a significant reduction in 
Streptococcus. The levels of Porphyromonas correlated with both disease progres-
sion and the immune dysregulation which is considered as the main culprit in the 
development of the disease [18].
Qiaozhen Yang et al. (2017) conducted a study utilizing RNA sequencing in the 
detection of genes responsible for malignant transformation of oral lichen planus 
to oral squamous cell carcinoma. Around 19 common differently expressed genes 
associated with oral lichen planus and OSCC were detected. Further analysis using 
polymerase chain reaction test revealed that among these 19 genes BCL9L, GMPS, 
HES1, PER2 and TSPAN33 were associated with the malignant transformation of 
oral lichen planus [19].
In another study conducted by Qiaozhen Yang et al. in 2017 they evaluated the 
role of differentially expressed genes and IncRNAs in the malignant transforma-
tion of oral lichen planus. The mapping of the IncRNAs were conducted using 
RNA sequencing. From the study it was concluded that keratininsation and major 
histocompatibility complex class I antigen processing and also the antigen presenta-
tion was activated during malignant transformation of oral lichen planus and found 
that numerous genes were expressed as well.
Junjun Chen et al. (2017) in their study on evaluation of the role of differen-
tially expressed miRNAs and differentially expressed genes using next generation 
sequencing with DESeq. The gene expression profiling suggested a possible role in 
the development and progression of lichen planus [19].
In a study conducted by Keumjin Baek (2020), used high throughput sequenc-
ing of 16S rRNA gene to identify the bacterial communities present in lesions of 
oral lichen planus to recognize the role of these organisms in the pathogenesis of 
oral lichen planus. Both high throughput sequencing of 16S rRNA gene and whole 
genome sequencing revealed that there was an elevation in E.coli in biopsy tissues 
obtained from patients with oral lichen planus which is suggestive of potential role 
in triggering or developing the disease [20].
Studies in lichen planus done with RNA sequencing revealed newer clues as to 
possible role of oral microbiota in the development as well as progression of oral 
lichen planus. There are numerous gene expression studies which showed that 
there are variations in the expression profile. Like with the other two PMODs, RNA 
sequencing may play an important role in diagnostic and prognostic evaluation of 
lichen planus (Figure 4).
Figure 4. 
Applications of RNA sequencing in oral lichen planus.
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9. Scope of RNA sequencing in potentially malignant oral disorders
Potentially Malignant oral disorders have eluded the medical community for 
long due to lack of the right means to assess its molecular signature. Ground break-
ing research focusing on new molecular techniques to assess the molecular signature 
set by the Potentially malignant oral disorders is the need of the hour. RNA profiling 
serves to be a valuable tool in deciphering the molecular signature and serves as a 
guiding light on which the therapeutics working on similar principles can be based.
10. RNA sequencing aiding in generation of molecular signature
A significant advantage of RNA sequencing over the other diagnostic techniques 
is that it is based on Next generation sequencing where in the complete set of 
altered genome can be assessed through transcriptome analysis, thereby providing 
a comprehensive outlook on the genetic profile of a disease model. This elaborate 
guide of genetic set up of the disease serves to provide a valuable insight into the 
unique molecular signature of a particular disease, thereby enabling prompt and 
accurate diagnosis of the disease [21].
10.1 Sensitivity and specificity
RNA profiling is characteristically known for its high degree of sensitivity and 
specificity as it encodes for genetic alterations at the nuclear level and hence can be 
used as a confirmatory tool in the diagnosis of PMODs and elimination of Oral can-
cer in cases where clinical and histological appearance can be elusive and misleading.
10.2 RNA therapeutics
RNA therapeutics is a branch of therapeutics dealing with treatment strategies 
targeting the RNA profile of the disease which is unique to the individual. RNA 
profiling provides details about the genomic alterations unique to a particular 
individual. Targeted therapy towards the altered components of the genome helps 
eliminating the disease and offers better prognosis and avoids recurrence, thereby 
improving the overall survival and disease free survival rates of the individual [22].
10.3 Monitoring the prognosis and prediction of recurrence
The treatment protocol for most disorders is standard and has been in practice 
for decades, however, a proper protocol to assess the prognosis and the propensity 
for recurrence has not been established for any disease model. Obtaining the RNA 
profile of the individual suffering from PMODs can not only aid in diagnosis and 
treatment planning, but also serve as a tool in predicting the prognosis of the 
disease. Several genes, she upregulated serves as a poor prognostic marker where as 
several unregulated genes serve as markers of good prognosis and decreased recur-
rence rates. Hence obtaining the genomic profile through RNA sequencing can serve 
to be a valuable tool in predicting the same, thereby improving the overall quality of 
life of the individual post treatment.
10.4 RNA sequencing-a tool for research continuum
Apart from offering patient specific and disease specific outcomes, obtaining 
the RNA profile of a particular disease will serve as a valuable tool for furthering 
9
RNA Sequencing in Potentially Malignant Disorders
DOI: http://dx.doi.org/10.5772/intechopen.97712
Author details
Ramya Ramadoss1*, Rajkumar Krishnan2, Lekshmy Jayan2  
and Priyadharini Shankaran2
1 Department of Oral Pathology, Saveetha Dental College, Chennai, India
2 Department of Oral Pathology, SRM Dental College, Chennai, India
*Address all correspondence to: drramya268@gmail.com
the cause of research pertaining to the particular disease. Most of the data obtained 
through RNA profiling is specific and permanent. It is not subject to change over 
a period of time. Thus RNA sequencing profile obtained can be used in further 
research, aimed at diagnosis and development of targeted therapeutics, thereby 
enabling continuous research up gradation.
11. Conclusion
RNA sequencing is an advanced diagnostic aid that serves to be a valuable tool 
in diagnosis, targeted therapy and prognostic marker for Potentially Malignant 
Oral Disorders. The technique is highly sensitive and specific and provides valuable 
information regarding the genomic set up of a particular disease. We have sum-
marized the potential genetic alterations in PMODs and highlighted the research 
efforts undertaken in order to obtain the RNA profile of the particular disease. The 
knowledge of RNA profile added with the clinical data can serve to be a diagnostic 
tool par excellence in detecting Potentially Malignant Oral Disorders.
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
10
Applications of RNA-Seq in Biology and Medicine
[1] Kukurba KR, Montgomery SB. RNA 
sequencing and analysis. Cold Spring 
Harbor Protocols. 2015 Nov 
1;2015(11):pdb-top084970.
[2] Stark R, Grzelak M, Hadfield J. RNA 
sequencing: the teenage years. Nature 
Reviews Genetics. 2019 
Nov;20(11):631-656.
[3] Ganesh D, Sreenivasan P, Öhman J, 
Wallström M, Braz-Silva PH, Giglio D, 
Kjeller G, Hasseus B. Potentially 
malignant oral disorders and cancer 
transformation. Anticancer research. 
2018 Jun 1;38(6):3223-3229.
[4] Ma JM, Zhou TJ, Wang R, Shan J, 
Wu YN, Song XL, Gu N, Fan Y. Brush 
biopsy with DNA-image cytometry: a 
useful and noninvasive method for 
monitoring malignant transformation 
of potentially malignant oral disorders. 
European Archives of Oto-Rhino-
Laryngology. 2014 Dec;271(12): 
3291-3295.
[5] Yap T, Celentano A, Seers C, 
McCullough MJ, Farah CS. Molecular 
diagnostics in oral cancer and oral 
potentially malignant disorders—A 
clinician’s guide. Journal of Oral 
Pathology & Medicine. 2020 
Jan;49(1):1-8.
[6] George A, Sreenivasan BS, Sunil S, 
Varghese SS, Thomas J, Gopakumar D, 
Mani V. Potentially malignant disorders 
of oral cavity. Oral Maxillofac Pathol J. 
2011 Jan 1;2(1):95-100.
[7] Ozsolak F, Milos PM. RNA 
sequencing: advances, challenges and 
opportunities. Nature reviews genetics. 
2011 Feb;12(2):87-98.
[8] Griffith M, Griffith OL, 
Mwenifumbo J, Goya R, Morrissy AS, 
Morin RD, Corbett R, Tang MJ, Hou YC, 
Pugh TJ, Robertson G. Alternative 
expression analysis by RNA sequencing. 
Nature methods. 2010 Oct;7(10):843.
[9] Farah CS, Fox SA. Dysplastic oral 
leukoplakia is molecularly distinct from 
leukoplakia without dysplasia. Oral 
diseases. 2019 Oct;25(7):1715-1723.
[10] Philipone E, Yoon AJ, Wang S, 
Shen J, Ko YC, Sink JM, Rockafellow A, 
Shammay NA, Santella RM. 
MicroRNAs-208b-3p, 204-5p, 129-2-3p 
and 3065-5p as predictive markers of 
oral leukoplakia that progress to cancer. 
American journal of cancer research. 
2016;6(7):1537.
[11] Chang YA, Weng SL, Yang SF, 
Chou CH, Huang WC, Tu SJ, Chang TH, 
Huang CN, Jong YJ, Huang HD. A 
three–microRNA signature as a 
potential biomarker for the early 
detection of oral cancer. International 
journal of molecular sciences. 2018 
Mar;19(3):758.
[12] Xu S, Song Y, Shao Y, Zhou H. 
Comprehensive analysis of circular RNA 
in oral leukoplakia: upregulated 
circHLA-C as a potential biomarker for 
diagnosis and prognosis. Annals of 
Translational Medicine. 2020 
Nov;8(21).
[13] Pindborg JJ, Sirsat SM. Oral 
submucous fibrosis. Oral Surgery, Oral 
Medicine, Oral Pathology. 1966 Dec 
1;22(6):764-779.
[14] Tsai CH, Chou MY, Chang YC. The 
up-regulation of cyclooxygenase-2 
expression in human buccal mucosal 
fibroblasts by arecoline: a possible role 
in the pathogenesis of oral submucous 
fibrosis. Journal of oral pathology & 
medicine. 2003 Mar;32(3):146-153.
[15] Zhou S, Zhu Y, He Z, Zhang D, 
Guo F, Jian X, Zhang C. Long non-
coding RNA expression profile 
References
11
RNA Sequencing in Potentially Malignant Disorders
DOI: http://dx.doi.org/10.5772/intechopen.97712
associated with malignant progression 
of oral submucous fibrosis. Journal of 
oncology. 2019 Jul 29;2019.
[16] Zhou S, Qu X, Yu Z, Zhong L, 
Ruan M, Ma C, Wang M, Zhang C, 
Jian X. Survivin as a potential early 
marker in the carcinogenesis of oral 
submucous fibrosis. Oral Surgery, Oral 
Medicine, Oral Pathology, Oral 
Radiology, and Endodontology. 2010 
Apr 1;109(4):575-581.
[17] Le Cleach L, Chosidow O. Lichen 
planus. New England Journal of 
Medicine. 2012 Feb 23;366(8):723-732.
[18] Chen J, Wang Y, Du G, Zhang W, 
Cao T, Shi L, Wang Y, Mi J, Tang G. 
Down-regulation of miRNA-27b-3p 
suppresses keratinocytes apoptosis in 
oral lichen planus. Journal of cellular 
and molecular medicine. 2019 
Jun;23(6):4326-4337.
[19] Yang Q , Guo B, Sun H, Zhang J, 
Liu S, Hexige S, Yu X, Wang X. 
Identification of the key genes 
implicated in the transformation of OLP 
to OSCC using RNA-sequencing. 
Oncology reports. 2017 Apr 
1;37(4):2355-2365.
[20] Baek K, Choi Y. The microbiology of 
oral lichen planus: Is microbial infection 
the cause of oral lichen planus?. 
Molecular oral microbiology. 2018 
Feb;33(1):22-28.
[21] Burnett JC, Rossi JJ. RNA-based 
therapeutics: current progress and 
future prospects. Chemistry & biology. 
2012 Jan 27;19(1):60-71.
[22] Marinov GK. On the design and 
prospects of direct RNA sequencing. 
Briefings in functional genomics. 2017 
Nov 1;16(6):326-335.
